Global Oligonucleotide Synthesis Market- Regional Analysis
Among regions, North America is estimated to hold a dominant position in the global oligonucleotide synthesis market over the forecast period. North America is estimated to hold 39.7% of the market share in 2023. The global oligonucleotide synthesis market is expected to witness significant growth in the coming years, owing to the increasing adoption of inorganic growth strategies such as collaboration by key market players in the region. For instance, in January 2022, Maravai LifeSciences, Inc., a life science company, announced that it had acquired MyChem, LLC, manufacturer of ultrapure nucleotides, for US$240 million in cash. This acquisition continues their journey to develop and integrate strategic mRNA vaccines and therapeutic supply chain inputs into operations in the U.S. Under this acquisition, MyChem's portfolio complements Maravai's nucleic acid production products and is expected to provide significant benefits to customers through an integrated offering. Additionally, MyChem will help accelerate Maravai's innovation capabilities with additional research and development resources.
Oligonucleotide Synthesis Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients